Thermo Fisher Scientific | TMO - Ordinary Share Capital


Thermo Fisher Scientific reported $371.62M in Ordinary Share Capital for its fiscal quarter ending in March of 2026.





Ordinary Share Capital Change Date
Abbott USD 1.74B 23.39B Sep/2025
Agilent USD 282.22M 478K Mar/2026
Becton, Dickinson and Co. USD 284.91M 1.72M Dec/2025
Bio Techne USD 156.45M 703K Mar/2026
Bio-Rad Laboratories USD 26.99M 18K Dec/2025
Boston Scientific USD 1.48B 2.66M Dec/2025
Bruker USD 152.22M 282K Mar/2026
Charles River Laboratories USD 48.17M 1.05M Mar/2026
Danaher USD 707.7M 800K Mar/2026
Dentsply International USD 200.3M 700K Mar/2026
Edwards Lifesciences USD 580.7M 0 Dec/2025
General Electric Aerospace USD 1.04B 5.43M Mar/2026
Henry Schein USD 114.42M 1.35M Mar/2026
Illumina USD 151.91M 893K Mar/2026
Intuitive Surgical USD 355.17M 674K Mar/2026
IQVIA Holdings USD 166.9M 2.7M Mar/2026
Laboratory Of America USD 82.3M 100K Mar/2026
Medtronic USD 1.28B 1.38M Dec/2025
Mettler Toledo International USD 20.25M 179.94K Mar/2026
Myriad Genetics USD 93.5M 400K Dec/2025
Olympus JPY 1.1B 35.42K Mar/2026
OraSure Technologies USD 70.39M 1.87M Dec/2025
Quest Diagnostics USD 111M 1000K Mar/2026
Repligen USD 56.4M 74K Mar/2026
Revvity USD 111.8M 1.57M Mar/2026
Stryker USD 382.98M 584K Mar/2026
Thermo Fisher Scientific USD 371.62M 4.09M Mar/2026
Veracyte USD 79.79M 743K Mar/2026
Waters USD 98.17M 89K Mar/2026
Zimmer Biomet Holdings USD 195.5M 2.68M Mar/2026